Visionary minds.
Enhanced by AI

Our everyday lives are becoming increasingly digital. Microchips are now found in smartphones, household appliances, computers and cars, enabling innovations such as automation, autonomous driving and AI. This places enormous demands on the computingpower and performance of IT systems, challenging the semiconductor industry to produce ever smaller, more powerful and more energy-efficient computer chips. ZEISS Semiconductor Manufacturing Technology (SMT) uses high-precision optics to enable chip manufacturers around the world to produce the technologies of the future.

Microchips featuring structures 5,000 times finer than a human hair are enable AI to "learn". These high-end microchips are produced using EUV lithography optics from ZEISS and enable enormous amounts of data to be processed in no time at all – the basis for AI applications. ZEISS SMT has successfully made the technological leap to EUV lithography in collaboration with its partners. This upholds Moore’s Law into the second half of this decade, allowing even more transistors to be placed on a microchip. Going forward, ZEISS SMT and the new High-NA EUV lithography will enable the semiconductor industry to produce the next generation of microchips. This in turn will drive future trends and progress in the field of AI.

For ZEISS Industrial Quality & Research, AI is a key enabler. The segment embeds AI in products, solutions and processes, helping customers enhance their efficiency and gain new knowledge and understanding. At the same time, advanced metrology and microscopy solutions from ZEISS are used in the manufacture of more powerful AI servers and the optimization of semiconductors. With its broad product portfolio, the segment thus makes a significant contribution to global megatrends such as digitalization, decarbonization, automation,sustainability and health.

ZEISS Research Microscopy Solutions integrates AI in microscopy solutions along the workflow from image capture to data analysis. AI algorithms improve image quality and identify and classify structures and objects in microscopic images. This allows cell cultures, for example, to be analyzed more quickly. Integrated AI solutions enable customers to minimize errors when analyzing large amounts of data and to work more accurately, efficiently and reproducibly.

ZEISS Industrial Quality Solutions uses AI to significantly advance the digitalization of quality and production control. AI-based solutions connect measurement and inspection data, detect deviations at an early stage and optimize production processes. This ensures greater efficiency, lowers resource consumption and enables faster decisions in production. ZEISS thus supports customers in key industries such as electromobility, electronics, aerospace, medical technology and energy generation, helping them to successfully navigate challenges such as decarbonization and globalization.

The ZEISS Research Data Platform of the Medical Technologysegment is designed to transform opthalmology research workflows. As a cloud-based solution, it offers clinical teams and researchers the seamless integration of datasets and formats from multiple sources. This allows data from research and clinical settings to be standardized, enabling in-depth analyses, for example of diagnostic imaging data and relevant research data. ZEISS Research Data Platform (RDP) allows users to train their own algorithms and let AI handle complex, time-consuming data analysis. ZEISS RDP enables doctors and researchers to swiftly convert their scientific hypotheses into quantifiable biomarkers. Biomarkers can be detected by various ophthalmic imaging techniques and provide information about the health of the eye. New biomarkers can help, for example, with the early diagnosis of serious retinal diseases and support personalized treatment.

The future of healthcare is in the data, and the insights gained through AI can make personalized medical care possible. ZEISS RDP empowers clinical researchers in balancing their clinical practice and research activities.

In many regions of the world, the number of ophthalmology practices is decreasing even as eye care needs increase, making regular eye check-ups harder to access. Yet many cases of vision loss are preventable or respond well to treatment when detected early. This is where the idea of the ZEISS EyeCare Network from the Consumer Markets segment comes in, connecting opticians with ophthalmologists. In Germany, for instance, opticians provide services to around 80 percent of thepopulation and are thus the first port of call for many when it comes to good vision.

The ZEISS EyeCare Network enables qualified opticians to be an active part of medical eye check-ups for their customers right at optical stores. The opticians collect all relevant measurements and information from their customers, which are then assessed by ophthalmology specialists – in Germany, Austria and Switzerland through the ZEISS partner Ocumeda. The data is securely and compliantly transmitted via the ZEISS Eyecare Network platform. The customers of ZEISS partner opticians receive their ophthalmological report directly from the eye doctors by email or post, including a thorough evaluation and individual recommendations. With the ZEISS EyeCare Network, ZEISS enables partner opticians to make a significant contribution to the prevention of vision loss – directly on site, easily and in compliance with legal regulations. And it helps them to position themselves as a prevention hub. Thus, the new service directly contributes to the mission of ZEISS Vision Care to protect and improve the vision and visual health of consumers. Currently, the ZEISS EyeCare Network is available in Germany, Austria and Switzerland (in collaboration with Ocumeda).